Deals Shaping The Medical Industry, August 2019
Executive Summary
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced July 2019.
You may also be interested in...
After AR-105 VAP Failure, Aridis Looks To AR-301 For Value Justification
Aridis is effectively pulling the plug on AR-105 after the mAb failed in a Phase II ventilator-associated pneumonia trial. It will now focus on its remaining pipeline, led by Phase III asset AR-301.
Smart Homes, AI-Assisted Devices, Home Security – Connected Health Summit Puts Spotlight On Independent Living
The Connected Health Summit conference, held from 27-29 August in San Diego, CA, will spotlight smart, connected home-care technology.
Device/Diagnostics Quarterly Dealmaking Statistics, Q1 2020
Device financing totaled $1.4bn during the first quarter of 2020. Merger and acquisition activity reached $714.5m, with only two transactions hitting the six-figure mark. Financings by diagnostics/research players totaled $985m and just six companies were acquired, four of which together were valued at $11.6bn, most coming from Thermo Fisher Scientific’s $11.5bn buy of fellow public life sciences company Qiagen NV.
Need a specific report? 1000+ reports available
Buy Reports